The U.S. Food and Drug Administration (FDA) has cleared updated software for the Heidelberg Engineering Spectralis retinal imaging platform, introducing a 250 kHz scan speed for optical coherence tomography (OCT) angiography and a new green autofluorescence module. The update, designed to improve the speed and precision of retinal disease assessment, is slated for commercial release later this year.
What the New Software Update Includes
The latest iteration of the Spectralis software focuses on increasing the efficiency of diagnostic imaging. According to a company press release, the primary addition is an increase in OCT angiography (OCTA) scan speed to 250 kHz. This high-speed capability complements the platform’s existing 85 kHz and 125 kHz settings.
In addition to the faster scan speeds, the update integrates a green autofluorescence (GAF) module. This feature is intended to enhance macular imaging, allowing clinicians to visualize retinal structures with greater clarity. By providing a wider array of imaging modalities, the software aims to assist ophthalmologists in the detection and monitoring of complex retinal pathologies.
Why Speed Matters in Retinal Imaging
In clinical practice, scan speed directly influences both image quality and patient comfort. Faster acquisition times, such as the 250 kHz speed now supported by the Spectralis, reduce the duration a patient must remain still, which minimizes motion artifacts—blurring caused by eye movement or blinking during the scan.
According to Heidelberg Engineering, this update is part of a broader effort to integrate speed, precision, and multimodal imaging into a single diagnostic workflow. By reducing the time required for high-resolution angiography, clinicians can potentially improve throughput in busy clinics while maintaining the diagnostic detail necessary for managing conditions like age-related macular degeneration or diabetic retinopathy.
Comparison of OCT Angiography Capabilities
The following table outlines the scan speed progression for the Spectralis platform as detailed in recent product specifications:
| Feature | Existing Capability | New Update |
|---|---|---|
| OCT Angiography Speed | 85 kHz / 125 kHz | 250 kHz |
| Macular Imaging | Standard Autofluorescence | Green Autofluorescence |
What Clinicians Should Expect Next
Heidelberg Engineering has indicated that the software will be commercially available to practitioners later in 2024. While the FDA has cleared the software for use, the rollout will occur in phases as the company updates its installed base of Spectralis systems.
Clinicians interested in the new features should contact their local Heidelberg Engineering representative to determine when the update will be available for their specific hardware configurations. As with all diagnostic software, the transition to higher scan speeds may require brief staff training to optimize image acquisition protocols and data interpretation.